Among the 18 plasma molecules, CASH patients showed lower plasma levels of sCD14 (AUC = 72%, P = 0.001, 52% sensitivity, 87% specificity) (A and B), VEGF (AUC = 69%, P = 0.01, 89% sensitivity, 54% specificity) (C and D), and IL-10 (AUC = 66%, P = 0.04, 61% sensitivity, 70% specificity) (G and H), along with higher CRP (AUC = 66%, P = 0.03, 94% sensitivity, 42% specificity) plasma levels (E and F). The plasma levels of the 18 plasma molecules were compared between CASH and non-CASH patients using a 2-tailed 2-sample t test with an FDR correction. **P < 0.01, ***P < 0.001. Data represent mean ± SEM.